Brief: Biolidics Obtained Relevant Product Liability Insurance For Clearepi NAB Test
Dec 8 (Reuters) - Biolidics Ltd BIOL.SI :
* OBTAINED RELEVANT PRODUCT LIABILITY INSURANCE FOR CLEAREPI
NAB
TEST
* ENTERED INTO DEFINITIVE MANUFACTURING AGREEMENT FOR
PRODUCTION
OF ITS CLEAREPI SARS-COV-2 NEUTRALISING ANTIBODY RAPID TEST KIT
* COMMERCIAL PRODUCTION FOR CLEAREPI NAB TEST BY CO IS
EXPECTED TO
COMMENCE IN CURRENT FY 2021
Source text for Eikon: ID:nSN9WLY80
Further company coverage: BIOL.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Embracing Future Holdings
See all newsBrief: Embracing Future To Buy 10% Of Embracing Future Biomedical For S$6.7 Million
Brief: Biolidics Posts FY Pretax Profit SGD -3.187 Million
Brief: Biolidics Ltd To Acquire Shenzhen Xiaozhao Network Technology
Brief: Biolidics Announces Resignation Of Song Tang Yih As Executive Director And CEO
Brief: Biolidics Announces Cybersecurity Incident